Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more
Daxor Corporation (DXR) - Total Assets
Latest total assets as of June 2025: $35.90 Million USD
Based on the latest financial reports, Daxor Corporation (DXR) holds total assets worth $35.90 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Daxor Corporation - Total Assets Trend (1985–2024)
This chart illustrates how Daxor Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Daxor Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Daxor Corporation's total assets of $35.90 Million consist of 0.1% current assets and 100.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $9.68K | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1985–2024)
This chart illustrates how Daxor Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Daxor Corporation's current assets represent 0.1% of total assets in 2024, a decrease from 97.1% in 1985.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 95.4% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1985.
- Asset Diversification: The largest asset category is accounts receivable at 0.0% of total assets.
Daxor Corporation Competitors by Total Assets
Key competitors of Daxor Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Daxor Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Daxor Corporation generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Daxor Corporation generates $ 1.46 in net profit.
Daxor Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.17 | 0.25 | 0.42 |
| Quick Ratio | 0.17 | 0.25 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-91.76K | $ -77.22K | $ -46.01K |
Daxor Corporation - Advanced Valuation Insights
This section examines the relationship between Daxor Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.02 |
| Latest Market Cap to Assets Ratio | 0.79 |
| Asset Growth Rate (YoY) | 5.1% |
| Total Assets | $36.63 Million |
| Market Capitalization | $29.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values Daxor Corporation's assets below their book value (0.79 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Daxor Corporation's assets grew by 5.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Daxor Corporation (1985–2024)
The table below shows the annual total assets of Daxor Corporation from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $36.63 Million | +5.06% |
| 2023-12-31 | $34.87 Million | +15.23% |
| 2022-12-31 | $30.26 Million | +21.13% |
| 2021-12-31 | $24.98 Million | +50.92% |
| 2020-12-31 | $16.55 Million | +16.56% |
| 2019-12-31 | $14.20 Million | -19.43% |
| 2018-12-31 | $17.63 Million | -8.72% |
| 2017-12-31 | $19.31 Million | -6.37% |
| 2016-12-31 | $20.62 Million | -1.29% |
| 2015-12-31 | $20.89 Million | -54.63% |
| 2014-12-31 | $46.05 Million | -2.84% |
| 2013-12-31 | $47.39 Million | -15.86% |
| 2012-12-31 | $56.33 Million | -34.29% |
| 2011-12-31 | $85.72 Million | -6.00% |
| 2010-12-31 | $91.20 Million | +21.29% |
| 2009-12-31 | $75.19 Million | -2.13% |
| 2008-12-31 | $76.82 Million | -25.09% |
| 2007-12-31 | $102.56 Million | +31.21% |
| 2006-12-31 | $78.17 Million | +31.23% |
| 2005-12-31 | $59.57 Million | +6.50% |
| 2004-12-31 | $55.93 Million | +15.79% |
| 2003-12-31 | $48.30 Million | +16.18% |
| 2002-12-31 | $41.57 Million | -4.52% |
| 2001-12-31 | $43.54 Million | -12.17% |
| 2000-12-31 | $49.58 Million | +38.30% |
| 1999-12-31 | $35.85 Million | -18.72% |
| 1998-12-31 | $44.10 Million | +6.78% |
| 1997-12-31 | $41.30 Million | +10.72% |
| 1996-12-31 | $37.30 Million | -1.06% |
| 1995-12-31 | $37.70 Million | +7.71% |
| 1994-12-31 | $35.00 Million | +20.27% |
| 1993-12-31 | $29.10 Million | -10.74% |
| 1992-12-31 | $32.60 Million | +11.64% |
| 1991-12-31 | $29.20 Million | -9.03% |
| 1990-12-31 | $32.10 Million | +21.13% |
| 1989-12-31 | $26.50 Million | -12.54% |
| 1988-12-31 | $30.30 Million | +25.73% |
| 1987-12-31 | $24.10 Million | +13.15% |
| 1986-12-31 | $21.30 Million | +21.71% |
| 1985-12-31 | $17.50 Million | -- |